The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy - Xu, Xin; Zhao, Wei; Liu, Cuicui; Gao, Yongsheng; Chen, Dawei; Wu, Meng; Li, Chao; Wang, Xinzhao; Song, Xiang; Yu, Jinming; Liu, Zhaoyun; Yu, Zhiyong (BMC cancer, 2024)
Keywords: Adjuvant treatment; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Breast cancer; Breast Neoplasms - pathology; Cancer; Cancer patients; Cancer therapies; Care and treatment; Chemotherapy; Classification; Comorbidity; Comparative analysis; Development and progression; Diagnosis; ErbB-2 protein; Female; Gene amplification; Humans; Medical prognosis; Medical records; Metastasis; Miller-Payne grading; Neoadjuvant chemotherapy; Neoadjuvant Therapy; Neoplasm Recurrence, Local - drug therapy; Neoplasm, Residual - pathology; Oncology, Experimental; Pathologic complete response; Pathology; Patients; Prognosis; Recurrence; Regression analysis; Residual cancer burden; Retrospective Studies; Risk factors; Statistical analysis; Surgery; Triple Negative Breast Neoplasms - pathology; China; Taiwan; Neoadjuvant chemotherapy; Pathologic complete response; Breast cancer; Residual cancer burden; Miller-Payne grading